What drives other people to kill? Is it the domain of other people special or are we all capable of doing it?
Indian law and the formula of justice for criminals do not have a real intellectual aptitude and how to deal with criminals.
Does nature or nurture make a murderer?Does water retain the obsolete but still overused “psychopath”?
Who is a “psychopath” and, if he exists, how can we prevent them from believing more?
The Gujarat Congress has been decimated to the point that it even qualifies for the post of opposition leader in the State Assembly.
Updated: December 2022: 14
Currently, Covaxin from Bharat Biotech, Covishield and Covovax from Serum Institute, Russian Sputink V and Corbevax from Biological E Ltd are indexed on the CoWin portal. The vaccine maker announced on Sept. 6 that its iNCOVACC (BBV154), the world’s first COVID-19 intranasal vaccine, has won approval from India’s Comptroller General of Medicines for limited emergency use for people 18 and older. “There have been no procurement requests from state or central governments,” the resources added.
The city-based vaccine maker also plans to export the iNCOVACC to countries once it gets approvals from the respective countries, the resources added. years and older in India for heterologous booster doses.
The vaccine evolved in collaboration with the University of Washington, St. Louis, who had designed and developed the recombinant adenoviral vector and evaluated its efficacy in preclinical studies. The vaccine candidate has undergone phase I, II and III clinical trials with positive effects and has in particular formulated to allow intranasal management through nasal drops. Phase III trials for protection and immunogenicity have been conducted on approximately 3100 subjects at 14 trial sites across India.
© 2022 Outlook Publishing India Pvt. Limited